Yahoo
OTC Markets OTCQX - Delayed Quote USD

Green Thumb Industries Inc. (GTBIF)

6.78 +0.53 (+8.48%)
At close: November 6 at 4:00:00 PM EST
Chart Range Bar
Loading chart for GTBIF
  • Previous Close 6.25
  • Open 6.31
  • Bid 6.76 x 180000
  • Ask 6.81 x 15000
  • Day's Range 6.25 - 7.03
  • 52 Week Range 5.29 - 10.43
  • Volume 302,737
  • Avg. Volume 501,764
  • Market Cap (intraday) 1.482B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 16.14
  • EPS (TTM) 0.42
  • Earnings Date Nov 4, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 16.00
  • Morningstar Rating Rating available with Stock Picks access

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, capsules, tinctures, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, RYM, and RHYTHM brands. It distributes its products to third-party licensed retail customers; and sells finished products to third-party licensed retail cannabis stores. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.

www.gtigrows.com

5,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

GTBIF
15.88%
S&P/TSX Composite index (^GSPTSE)
12.31%

1-Year Return

GTBIF
1.02%
S&P/TSX Composite index (^GSPTSE)
18.89%

3-Year Return

GTBIF
25.49%
S&P/TSX Composite index (^GSPTSE)
80.53%

5-Year Return

GTBIF
67.82%
S&P/TSX Composite index (^GSPTSE)
66.80%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 324.41M
Earnings -4.83M
Profit Margin -1.49%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
100M
200M
300M
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%

Analyst Insights

View More

Analyst Price Targets

10.00
16.00 Average
6.78 Current
20.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 5/10/2024
Analyst Wedbush
Rating Action Maintains
Rating Outperform
Price Action Raises
Price Target 15 -> 16

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    0.42

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: